The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Education Dept. Goes Viral with Takedown of ‘Fake News’ Story on Loan Cuts: No More Handouts for Failing Degrees
Even Healthcare Workers Are Dropping Health Coverage as Obamacare Premiums Hit New Heights
Death Row Inmate Christa Pike Kept Alive With Ventilator After Botched Execution as Hospital Staff Tries to ‘Save’ Her
Newsom slaps 25% tax on private detention centers in sweeping pushback against key Trump policy
Watch: No Word from Pro-Palestinian Gays After Islamic Preacher Encourages Men to Execute Them, Strike Women
Trump’s attempted assassin sent mysterious texts about 3D printer leading up to Butler, Pa. shooting: report
DHS exposes dilemma behind SCOTUS deportation fight: ‘We have two choices’
MAGA mom’s dire warning over tech guardrails as Trump puts pedal to the metal on race with China
‘Activist judge’ rules Congress cannot bar noncitizens from voting in federal elections
Activist network wants you scared of AI killing people — unless China’s using it
Boston-bound plane vanishes with 6 on board; Coast Guard launches search off Nantucket coast
Japan seeks US help to bring North Korean abductees home
Lawmaker’s stunned face and other viral moments cap rough week for political class
Top investigator in Biden-era election probe wanted to tear key constitutional right away from lawmakers
Look: Grok AI Leaves Only 1 Out of 40 Standing When Asked to ‘Remove the Fake Gods’ from Image
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Education Dept. Goes Viral with Takedown of ‘Fake News’ Story on Loan Cuts: No More Handouts for Failing Degrees
Even Healthcare Workers Are Dropping Health Coverage as Obamacare Premiums Hit New Heights
Death Row Inmate Christa Pike Kept Alive With Ventilator After Botched Execution as Hospital Staff Tries to ‘Save’ Her
Newsom slaps 25% tax on private detention centers in sweeping pushback against key Trump policy
Watch: No Word from Pro-Palestinian Gays After Islamic Preacher Encourages Men to Execute Them, Strike Women
Trump’s attempted assassin sent mysterious texts about 3D printer leading up to Butler, Pa. shooting: report
DHS exposes dilemma behind SCOTUS deportation fight: ‘We have two choices’
MAGA mom’s dire warning over tech guardrails as Trump puts pedal to the metal on race with China
‘Activist judge’ rules Congress cannot bar noncitizens from voting in federal elections
Activist network wants you scared of AI killing people — unless China’s using it
Boston-bound plane vanishes with 6 on board; Coast Guard launches search off Nantucket coast
Japan seeks US help to bring North Korean abductees home
Lawmaker’s stunned face and other viral moments cap rough week for political class
Top investigator in Biden-era election probe wanted to tear key constitutional right away from lawmakers
Look: Grok AI Leaves Only 1 Out of 40 Standing When Asked to ‘Remove the Fake Gods’ from Image
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
